MoneyWorks4Me

Concord Drugs informs about board meeting

02 Aug 2018 Evaluate

Concord Drugs has informed that the meeting of the Board of Directors of the Company is scheduled on 14/08/2018, to consider and approve the un-audited financial results for the quarter ended 30.06.2018; to fix the day, date, time and venue of the ensuing Annual General Meeting of the Company; and any other business with the permission of the Chair.

The above information is a part of company’s filings submitted to BSE.

 

Peers
Company Name CMP
Sun Pharma. Inds. 1741.60
Dr. Reddys Labs. 1222.80
Cipla 1326.90
Lupin 1914.75
Zydus Lifesciences 1124.50
View more..